Grants and Contributions
About this information
In June 2016, as part of the Open Government Action Plan, the Treasury Board of Canada Secretariat (TBS) committed to increasing the transparency and usefulness of grants and contribution data and subsequently launched the Guidelines on the Reporting of Grants and Contributions Awards, effective April 1, 2018.
The rules and principles governing government grants and contributions are outlined in the Treasury Board Policy on Transfer Payments. Transfer payments are transfers of money, goods, services or assets made from an appropriation to individuals, organizations or other levels of government, without the federal government directly receiving goods or services in return, but which may require the recipient to provide a report or other information subsequent to receiving payment. These expenditures are reported in the Public Accounts of Canada. The major types of transfer payments are grants, contributions and \'other transfer payments\'.
Included in this category, but not to be reported under proactive disclosure of awards, are (1) transfers to other levels of government such as Equalization payments as well as Canada Health and Social Transfer payments. (2) Grants and contributions reallocated or otherwise redistributed by the recipient to third parties; and (3) information that would normally be withheld under the Access to Information Act and the Privacy Act.
$70,000.00
Mar 1, 2026
Individual or sole proprietorship
Catalyst Grant: Analysis of CLSA Data - IMHA ECR
191276
The specific objective of this funding opportunity is to:
• Catalyze and support research efforts of Canadian researchers to use the available CLSA data to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.
$67,722.00
Mar 1, 2026
Individual or sole proprietorship
Catalyst Grant: Analysis of CLSA Data - IPPH Mandate
191256
The specific objective of this funding opportunity is to:
• Catalyze and support research efforts of Canadian researchers to use the available CLSA data to better understand how biological, medical, psychological, social, lifestyle and/or economic aspects of people’s lives have an impact on both maintaining health and the development of disease and disability as people age.
$850.00
Mar 1, 2026
Individual or sole proprietorship
Summer Program in Aging
191307
The specific objective of this funding opportunity is:
• To provide entry to the SPA 2026 program to trainees interested in the area of: Impact of climate change on the health of older persons.
$770.00
Mar 1, 2026
Individual or sole proprietorship
Summer Program in Aging
191303
The specific objective of this funding opportunity is:
• To provide entry to the SPA 2026 program to trainees interested in the area of: Impact of climate change on the health of older persons.
$797.00
Mar 1, 2026
Individual or sole proprietorship
Summer Program in Aging
191294
The specific objective of this funding opportunity is:
• To provide entry to the SPA 2026 program to trainees interested in the area of: Impact of climate change on the health of older persons.
$100,000.00
Mar 1, 2026
Individual or sole proprietorship
Project Grant - Priority Announcement - Cancer Survivorship
189045
The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
Research Areas:
This Priority Announcement will fund research in the following priority areas:
• Prevention and/or Early Detection of Cancer
o Research focused on primary and/or secondary cancer prevention.
o Research related to tertiary cancer prevention, minimal residual disease, or cancer recurrence will not be funded.
• Cancer Survivorship
o Research focused on:
• Late and long-term effects of cancer treatments;
• Cancer survivors’ experiences and outcomes; and/or
• Models of cancer survivorship care.
o Research related to end-of-life care will not be funded.
$100,000.00
Mar 1, 2026
Individual or sole proprietorship
Project Grant - Priority Announcement - Cancer Survivorship
189042
The CIHR Institute of Cancer Research (CIHR-ICR) has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
Research Areas:
This Priority Announcement will fund research in the following priority areas:
• Prevention and/or Early Detection of Cancer
o Research focused on primary and/or secondary cancer prevention.
o Research related to tertiary cancer prevention, minimal residual disease, or cancer recurrence will not be funded.
• Cancer Survivorship
o Research focused on:
• Late and long-term effects of cancer treatments;
• Cancer survivors’ experiences and outcomes; and/or
• Models of cancer survivorship care.
o Research related to end-of-life care will not be funded.
$100,000.00
Mar 1, 2026
Individual or sole proprietorship
Project Grant – Priority Announcement: Cystic fibrosis across the lifespan
189064
This Priority Announcement (PA) is led by the Institute of Circulatory and Respiratory Health (CIHR-ICRH), in partnership with Cystic Fibrosis Canada.
The CIHR-ICRH has the broad mandate of supporting research on the heart, lung, brain (stroke), blood, blood vessels, critical and intensive care, and sleep.
Cystic Fibrosis Canada has the mandate to act boldly for all Canadians living with cystic fibrosis so they can live longer, healthier, fuller lives.
This PA is focused the management of cystic fibrosis (CF) across the lifespan, including, but not limited to, data acquisition.
• The proposed research should inform the management of cystic fibrosis.
• The proposed research should consider and/or include more than one (1) developmental or intergenerational period over the lifespan. Examples include, but are not limited to:
o one developmental period such as before and after puberty or before and after age 18, or
o different developmental periods across generations (e.g. biological parent and fetus or offspring), or
o two (2) developmental periods in females related to puberty, child-bearing age and menopause.
For the purpose of this PA:
• Only research on the management of CF related symptoms and conditions which also fall into ICRH’s mandate will be considered.
Examples of eligible projects include, but are not limited to:
• Understanding the changing health issues of individuals with CF as they age
• Understanding the long-term effects of medications (including CF transmembrane conductance regulators (CFTR) modulators) in CF over the lifespan
• Understanding the impact of modulators on fetal development and early childhood
• Understanding changes in treatments as people with CF age
• Strategies to maintain and enhance lung health over the lifespan
• Transitions from pediatric to adult CF care
• Preventative strategies for cardiovascular and other complications
$25,000.00
Mar 1, 2026
Individual or sole proprietorship
PRIZE - Project Grant - PA: Prize: Early Career Investigator in Cancer
189139
This award was established to recognize the excellence of cancer research being conducted in Canada. This award will be given annually to the highest-ranking Early Career Researchers in the Project Grant competition that fall within the CIHR Institute of Cancer Research (CIHR-ICR) mandate:
• ICR has a mandate to support research that reduces the burden of cancer on individuals and families through prevention strategies, screening, diagnosis, effective treatments, psycho-social support systems, and palliation.
$100,000.00
Mar 1, 2026
Individual or sole proprietorship
Project Grant – Priority Announcement: Global Health Research - CRPPHE
189096
CIHR is committed to leverage the power of research to accelerate global health equity for all. The CIHR Framework for Action on Global Health Research 2021-2026 recognizes that CIHR must work globally because today’s most pressing health problems, and many of the most effective strategies to prevent, contain, and address them, are global. In alignment with this Framework, this priority announcement aims to grow global health research capacity and excellence.
Funding will be provided for applications that have a primary focus on global health research (as per CIHR’s definition) and that are relevant to one of the mandates below:
• Institute of Population and Public Health (IPPH)
• Centre for Research on Pandemic Preparedness and Health Emergencies (CRPPHE)